Tscan Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,049 | $536 | $566 | $7,211 |
Gross Profit | 1,049 | -580 | -688 | 5,931 |
EBITDA | -27,902 | -29,593 | -27,929 | -17,481 |
EBIT | -28,929 | -30,709 | -29,183 | -18,761 |
Net Income | -29,887 | -31,661 | -30,142 | -19,613 |
Net Change In Cash | 1,049 | 536 | 566 | 7,211 |
Free Cash Flow | -29,288 | -27,087 | -29,972 | -24,235 |
Cash | 133,118 | 242,159 | 140,513 | 133,359 |
Basic Shares | 118,700 | 113,425 | 94,875 | 94,835 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $21,049 | $13,535 | $10,141 | $1,085 |
Gross Profit | -67,104 | 8,398 | 6,813 | -19,492 |
EBITDA | -80,098 | -59,907 | -45,297 | -25,003 |
EBIT | -85,459 | -65,044 | -48,625 | -26,233 |
Net Income | -89,218 | -65,806 | -48,625 | -26,021 |
Net Change In Cash | 21,049 | 13,535 | 10,141 | 1,085 |
Cost of Revenue | -41,372 | 131,050 | ||
Free Cash Flow | -64,504 | -70,728 | -58,618 | -7,261 |
Cash | 133,359 | 120,027 | 161,405 | 34,791 |
Basic Shares | 65,599 | 24,048 | 23,907 | 24,938 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.25 |
2024-06-30 | -$0.28 |
2024-03-31 | -$0.32 |
2023-12-31 | -$0.21 |
